J Natl Compr Canc Netw
Dr. Alvaro Moreno-Aspitia, MD
- Medicare services, 2022
- 19,854
- Part D claims, 2023
- 114
- Publications
- 72
- Clinical trials
- 3
- Hospital affiliations
- 1
- Practice address
- 200 Ave F NE, Winter Haven, FL 33881
- Practice phone
- Call (727) 281-9257
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Winter Haven Hospital
Winter Haven, Florida
Find Dr. Moreno-Aspitia's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Alvaro Moreno-Aspitia is a hematologist and oncologist in Winter Haven, Florida
Dr. Moreno-Aspitia practices at Winter Haven Hospital in Winter Haven, Florida.
Dr. Moreno-Aspitia's NPI, 1952390684, was assigned on October 15, 2005. Dr. Moreno-Aspitia graduated from Universidad Nacional de Asuncion Faculty of Medicine in 1991. Dr. Moreno-Aspitia holds Florida license ME75111.
- NPI
- 1952390684NPI Registry (opens in a new tab)
- NPI enumeration date
- October 15, 2005
- NPI status
- Active
- Practice phone
- (727) 281-9257
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 61
- Medical school graduation
- 1991
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Practice Data
Dr. Alvaro Moreno-Aspitia practices at Winter Haven Hospital in Winter Haven, Florida
Dr. Moreno-Aspitia's primary practice is Winter Haven Hospital, at 200 Ave F NE, Winter Haven, FL 33881 in Polk County. The practice phone is (727) 281-9257.
- Winter Haven Hospital200 Ave F NE, Winter Haven, FL 33881 · Polk CountyPhone(727) 281-9257
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Alvaro Moreno-Aspitia is affiliated with 2 sites of care and 1 medical group
Dr. Moreno-Aspitia's primary practice is Winter Haven Hospital in Winter Haven, Florida. Dr. Moreno-Aspitia is also affiliated with Mayo Clinic Hospital. The medical group on file is St. Vincent's Healthcare.
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Alvaro Moreno-Aspitia's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Moreno-Aspitia practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Winter Haven Hospital | Available with a free account |
| +1 more affiliated site | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Alvaro Moreno-Aspitia is one of 693 hematologists and oncologists in Florida
Hematology and oncology is Dr. Moreno-Aspitia's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Moreno-Aspitia is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Moreno-Aspitia's licenses on file in 2 states: Florida and Oklahoma.
Specialties and state licenses
- Hematology and oncology, FloridaPrimary
- Oklahoma license
Clinical focus
Dmand AI lists breast cancer and prostate cancer among the conditions Dr. Moreno-Aspitia treats.
Hematologists and oncologists near Dr. Moreno-Aspitia
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Alvaro Moreno-Aspitia billed Medicare for 19,854 services in 2022
CMS data shows 19,854 Medicare services from Dr. Moreno-Aspitia across 33 procedure codes in 2022. Medicare paid $449,679 for them. Every service was in an office.
Dr. Moreno-Aspitia's Medicare services by type, 2021 to 2022
- 2021
- 2022
- Drugs given in the office
- 2021: 15,0742022: 18,42622%
- Tests and treatments
- 2021: 7302022: 7847%
- Office and hospital visits
- 2021: 4892022: 42413%
- Other services
- 2021: 02022: 144
- Surgery
- 2021: 802022: 765%
Dr. Moreno-Aspitia compared with the Florida median for hematologists and oncologists, 2022
- Dr. Moreno-Aspitia
- Florida median
- Medicare services
- 19,854vs 69728.5 times
- Part D claims
- 114vs 34167% below
Medians across 638 hematologists and oncologists in Florida with Dmand AI profiles that report each measure.
Dr. Moreno-Aspitia's most billed Medicare procedure codes, 2022
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Moreno-Aspitia?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Moreno-Aspitia and other hematologists and oncologists in Florida.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Alvaro Moreno-Aspitia's patients have a median age of 79
Across all payers, Dmand AI patient panel data puts Dr. Moreno-Aspitia's median patient age at 79, with 60% women.
Dr. Moreno-Aspitia's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 79
Patient panel by sex, all payers
- Women60%
- Men40%
Source: Dmand AI Patient Panel Data
Dr. Alvaro Moreno-Aspitia wrote 114 Medicare Part D claims in 2023
In 2023, Dr. Moreno-Aspitia wrote 114 Medicare Part D claims. They cover 4 drugs, with $188,863 in total drug cost. In 2022, CMS named 563 claims across 12 drugs.
Dr. Moreno-Aspitia's most prescribed drugs by claims, 2023
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2022 to 2023
- 2022
- 2023
- Claims for drugs CMS names
- 2022: 5632023: 11480%
Drugs named by CMS: 4 in 2023, 12 in 2022.
Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Alvaro Moreno-Aspitia has 72 publications on record
Dmand AI links 72 papers to Dr. Moreno-Aspitia, published from 2004 to 2024. 2021 was the busiest year, with 6. The most frequent topics are Breast Neoplasms, Antineoplastic Combined Chemotherapy Protocols and Receptor, ErbB-2. Dr. Moreno-Aspitia has published most often in Breast Cancer Res Treat. Dr. Moreno-Aspitia's most frequent co-authors are Edith Perez, MD, Saranya Chumsri, MD and Donald W. Northfelt, MD.
Dr. Moreno-Aspitia's papers by year, 2015 to 2024
Topics Dr. Moreno-Aspitia writes about most
- Breast Neoplasms
- Antineoplastic Combined Chemotherapy Protocols
- Receptor, ErbB-2
- Trastuzumab
- Antineoplastic Agents
- Chemotherapy, Adjuvant
- Neoadjuvant Therapy
- Neoplasm Metastasis
Dr. Moreno-Aspitia's most frequent co-authors
- Edith Perez, MD26 shared papers
- Saranya Chumsri, MD14 shared papers
- Donald W. Northfelt, MD11 shared papers
Recent publications by Dr. Moreno-Aspitia
See who Dr. Moreno-Aspitia researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Moreno-Aspitia works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Alvaro Moreno-Aspitia has worked on 3 clinical trials
Dmand AI links Dr. Moreno-Aspitia to 3 clinical trials, 3 of them phase 2 studies. 3 are still active or recruiting. Conditions studied include Carcinoma, Hepatocellular, Triple Negative Breast Neoplasms and Unilateral Breast Neoplasms. Academic and Community Cancer Research United sponsors the most, 2.
Conditions in Dr. Moreno-Aspitia's trials
- Carcinoma, Hepatocellular
- Triple Negative Breast Neoplasms
- Unilateral Breast Neoplasms
- Breast Neoplasms
- Inflammatory Breast Neoplasms
Investigators on the most trials with Dr. Moreno-Aspitia
- Carmen Calfa, Medical, Oncologist1 shared trial
- Ahmed Elkhanany1 shared trial
- Steven Jay Isakoff, MD, PhD1 shared trial
Recent clinical trials with Dr. Moreno-Aspitia
Estradiol in Treating Patients With ER Beta Positive, Triple Negative Locally Advanced or Metastatic Breast Cancer (opens in a new tab)
Multi-epitope Folate Receptor Alpha Peptide Vaccine, GM-CSF, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Alvaro Moreno-Aspitia received $3,464 in industry payments from 2016 to 2021
CMS Open Payments shows 18 general payments to Dr. Moreno-Aspitia from 8 drug and device companies from 2016 to 2021. Honoraria make up the largest share, 72% of the total. NanoString Technologies, Inc. paid the most, $2,602.
General payments to Dr. Moreno-Aspitia by program year, 2016 to 2021
General payments to Dr. Moreno-Aspitia by kind, 2016 to 2021
- Honoraria$2,50072%
- Food and beverage$95227%
- Education$120%
Companies that paid Dr. Moreno-Aspitia the most, 2016 to 2021
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Alvaro Moreno-Aspitia has 10 awards and honors on record
Dmand AI lists 10 awards for Dr. Moreno-Aspitia, most recently Mayo Distinguished Clinician in 2021.
Awards and honors for Dr. Moreno-Aspitia
- 2021
- Mayo Distinguished Clinician
- 2014
- Volunteer of Distinction Award
- 2005
- AAP Fellow
- The Best Doctors in America
- 2004
- Teacher of the Year (Hematology/Oncology) - Department of Internal Medicine
- 2003
- Guide to America's Top Physicians
Source: Dmand AI Professional Profile Data
Dr. Alvaro Moreno-Aspitia graduated from Universidad Nacional de Asuncion Faculty of Medicine
Dr. Moreno-Aspitia graduated from Universidad Nacional de Asuncion Faculty of Medicine in 1991. Dr. Moreno-Aspitia is a member of AOA, AAP, ACP, ASCO and ASH.
- Medical school
- Board certified in hematology
- Board certified in internal medicine
- Board certified in medical oncology
- Board certified in pediatrics
Source: Dmand AI Professional Profile Data
Dr. Alvaro Moreno-Aspitia accepts plans from 4 insurance carriers
Dr. Moreno-Aspitia is in network with 4 carriers, including Excellus BlueCross BlueShield, Cigna and DE State Medicaid. Medicaid plans come from the most carriers, 2. Check the plan with the practice before a visit.
- Excellus BlueCross BlueShield
- Cigna
- DE State Medicaid
- GA State Medicaid
Plan types Dr. Moreno-Aspitia accepts, by number of carriers
- Medicaid2
- PPO2
- EPO1
- HMO1
- Medicare1
- POS1
Source: Dmand AI Insurance Network Data
Sources for Dr. Alvaro Moreno-Aspitia's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Awards and committee roles | Dmand AI Professional Profile Data |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Alvaro Moreno-Aspitia
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Alvaro Moreno-Aspitia's NPI number?
Dr. Alvaro Moreno-Aspitia's NPI number is 1952390684. It was assigned on October 15, 2005, and it is active in the NPI Registry.
What kind of doctor is Dr. Alvaro Moreno-Aspitia?
Dr. Alvaro Moreno-Aspitia is a hematologist and oncologist in Winter Haven, Florida. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Alvaro Moreno-Aspitia practice?
Dr. Moreno-Aspitia practices at 200 Ave F NE, Winter Haven, FL 33881. Dr. Moreno-Aspitia's primary practice is Winter Haven Hospital in Winter Haven, Florida.
What is Dr. Alvaro Moreno-Aspitia's office phone number?
The practice phone on file for Dr. Moreno-Aspitia is (727) 281-9257.
What is Dr. Alvaro Moreno-Aspitia's medical license number?
Dr. Moreno-Aspitia holds Florida license ME75111, one of the licenses on file in 2 states.
Which states has Dr. Alvaro Moreno-Aspitia been licensed in?
Dmand AI has state licenses on file for Dr. Moreno-Aspitia in Florida (1998 to 2026) and Oklahoma (2025 to 2026).
Which hospitals is Dr. Alvaro Moreno-Aspitia affiliated with?
Dr. Moreno-Aspitia is affiliated with Mayo Clinic Hospital.
What medical group is Dr. Alvaro Moreno-Aspitia part of?
Dr. Moreno-Aspitia is linked to St. Vincent's Healthcare.
Does Dr. Alvaro Moreno-Aspitia accept Medicare?
Yes. CMS data shows Dr. Moreno-Aspitia billed Medicare for 19,854 services in 2022.
Is Dr. Alvaro Moreno-Aspitia board certified?
Yes. Dr. Moreno-Aspitia is board certified in hematology by the American Board of Internal Medicine.
Show 8 more questionsShow fewer questions
What services does Dr. Alvaro Moreno-Aspitia bill to Medicare?
In 2022, Dr. Moreno-Aspitia's most billed Medicare services were injected or infused drug (J9271), injected or infused drug (J1453) and injected or infused drug (J9144).
Where did Dr. Alvaro Moreno-Aspitia go to medical school?
Dr. Moreno-Aspitia graduated from Universidad Nacional de Asuncion Faculty of Medicine in 1991.
What drugs does Dr. Alvaro Moreno-Aspitia prescribe most?
In 2023 Medicare Part D data, Dr. Moreno-Aspitia's most prescribed drugs by claims were Letrozole, Anastrozole and Exemestane.
Has Dr. Alvaro Moreno-Aspitia received payments from drug or device companies?
CMS Open Payments shows $3,464 in general payments to Dr. Moreno-Aspitia from 8 companies from 2016 to 2021. The largest total came from NanoString Technologies, Inc.
How long has Dr. Alvaro Moreno-Aspitia been practicing?
Dr. Moreno-Aspitia graduated from medical school in 1991, 35 years ago.
Does Dr. Alvaro Moreno-Aspitia do research?
Dmand AI links 72 publications to Dr. Moreno-Aspitia, published from 2004 to 2024. Dr. Moreno-Aspitia has worked on 3 clinical trials.
Who does Dr. Alvaro Moreno-Aspitia publish with?
Dr. Moreno-Aspitia's most frequent co-authors are Edith Perez, MD (26 shared papers), Saranya Chumsri, MD (14 shared papers) and Donald W. Northfelt, MD (11 shared papers).
What insurance does Dr. Alvaro Moreno-Aspitia accept?
Dr. Moreno-Aspitia is in network with 4 carriers, including Excellus BlueCross BlueShield, Cigna and DE State Medicaid. Medicaid plans come from the most carriers, 2. Check the plan with the practice before a visit.
Selling to hematology and oncology practices?
See hematologists and oncologists in Florida by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card